Good practice guideline: Promoting Early Identification of Systemic Anti-Cancer Therapies Side Effects: – Two Approaches.

Introduction Novel anti-cancer drugs such as targeted cancer therapies and immune check-point inhibitors (ICIs) have adverse events, especially concerning the skin. The aim of this study is to report an overview of the commonly consulted dermatological side effects of ICIs and targeted cancer therapies in clinical practice, along with their management. Methods In this single-center study, we evaluated consecutive oncological patients who were referred from the oncology outpatient clinic to the dermatology outpatient clinic due to skin side effects of ICIs and targeted therapies. All patients were examined and treated at the same day of referral by experienced dermatologists. Patient characteristics, clinical findings, diagnostic workups and treatments were retrieved from outpatient records. Results Sixty three patients were enrolled. Most common diagnoses were lung carcinoma, melanoma and colon carcinoma. Fifty patients (79%) were using targeted therapies while 13 (21%) were using ICIs. Xerosis was the most common side effect (44%), followed by acneiform rash, paronychia, eczema and pruritus. Majority of the side effects were grade 2 and 3. Psoriasis was a common side effect of ICIs. One patient had a newly developed dysplastic nevus on vemurafenib treatment. Oncological treatment was not withheld in any of the patients. Conclusions This study revealed the most commonly consulted skin side effects of novel anti-cancer drugs and their management in daily practice. We underlie the importance of collaborative work of oncology and dermatology professionals as early management of cutaneous side effects of targeted therapies and ICIs improves patient outcomes.

Download Full-text

Structure-Based Classification and Anti-Cancer Effects of Plant Metabolites

International Journal of Molecular Sciences ◽

10.3390/ijms19092651 ◽

2018 ◽

Vol 19 (9) ◽

pp. 2651 ◽

Cited By ~ 16

Author(s):

Seong-Ah Shin ◽

Sun Young Moon ◽

Woe-Yeon Kim ◽

Seung-Mann Paek ◽

Hyun Ho Park ◽

...

Keyword(s):

Side Effects ◽

Drug Development ◽

Human Population ◽

Negative Impact ◽

Cancer Drug ◽

Cancer Therapies ◽

Plant Metabolites ◽

Current State ◽

Anti Cancer ◽

Further Development

variety of malignant cancers affect the global human population. Although a wide variety of approaches to cancer treatment have been studied and used clinically (surgery, radiotherapy, chemotherapy, and immunotherapy), the toxic side effects of cancer therapies have a negative impact on patients and impede progress in conquering cancer. Plant metabolites are emerging as new leads for anti-cancer drug development. This review summarizes these plant metabolites with regard to their structures and the types of cancer against which they show activity, organized by the organ or tissues in which each cancer forms. This information will be helpful for understanding the current state of knowledge of the anti-cancer effects of various plant metabolites against major types of cancer for the further development of novel anti-cancer drugs.

Download Full-text

Manipulation of medicines to deliver a required dose: development of a good practice guideline

Archives of Disease in Childhood ◽

10.1136/archdischild-2013-303935a.22 ◽

2013 ◽

Vol 98 (6) ◽

pp. e1-e1

Author(s):

R. Richey ◽

C. Barker ◽

U. Shah ◽

M. Peak ◽

A. Nunn ◽

...

Keyword(s):

Practice Guideline ◽

Good Practice ◽

Good Practice Guideline

Download Full-text

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer

Case Medical Research ◽

10.31525/ct1-nct04071262 ◽

2019 ◽

Author(s):

Keyword(s):

Advanced Cancer ◽

Cancer Therapies ◽

Anti Cancer

Download Full-text

ANTICANCER EFFECT OF UVARIA GENUS

Journal of Medicine and Pharmacy ◽

10.34071/jmp.2013.6.16 ◽

2014 ◽

pp. 98-101

Author(s):

Thi Bich Hien Le ◽

Viet Duc Ho ◽

Thi Hoai Nguyen

Keyword(s):

Biological Activities ◽

Current Trend ◽

Healthcare Systems ◽

Chemical Compositions ◽

Cancer Therapies ◽

Pharmacological Effects ◽

Anticancer Effect ◽

Anti Cancer ◽

Tropical Areas ◽

Cancer Activity

Nowadays, cancer treatment has been a big challenge to healthcare systems. Most of clinical anti-cancer therapies are toxic and cause adverse effects to human body. Therefore, current trend in science is seeking and screening of natural compounds which possess antineoplastic activities to utilize in treatment. Uvaria L. - Annonaceae includes approximately 175 species spreading over tropical areas of Asia, Australia, Africa and America. Studies on chemical compositions and pharmacological effects of Uvaria showed that several compound classes in this genus such as alkaloid, flavonoid, cyclohexen derivaties, acetogenin, steroid, terpenoid, etc. indicate considerable biological activities, for example anti-tumor, anti-cancer, antibacterial, antifungal, antioxidant, etc. Specifically, anti-cancer activity of fractions of extract and pure isolated compounds stands out for cytotoxicity against many cancer cell lines. This study provides an overview of anti-cancer activity of Uvaria and suggests a potential for further studies on seeking and developing novel anti-cancer compounds. Key words: Anti-cancer, Uvaria.

Download Full-text

Targeting the Hippo Pathway for Anti-cancer Therapies

Current Medicinal Chemistry ◽

10.2174/0929867322666151002112256 ◽

2015 ◽

Vol 22 (35) ◽

pp. 4104-4117 ◽

Cited By ~ 12

Author(s):

Rui Gong ◽

Fa-Xing Yu

Keyword(s):

Hippo Pathway ◽

Cancer Therapies ◽

Anti Cancer ◽

The Hippo Pathway

Download Full-text

Nanoparticle-based Drug Delivery Systems for Targeted Epigenetics Cancer Therapy

Current Drug Targets ◽

10.2174/1389450121666200514222900 ◽

2020 ◽

Vol 21 (11) ◽

pp. 1084-1098

Author(s):

Fengqian Chen ◽

Yunzhen Shi ◽

Jinming Zhang ◽

Qi Liu

Keyword(s):

Drug Delivery ◽

Side Effects ◽

Cancer Therapy ◽

Drug Delivery Systems ◽

Therapeutic Index ◽

Delivery Systems ◽

Epigenetic Therapy ◽

Cancer Therapies ◽

Therapeutic Benefits ◽

High Therapeutic Index

This review summarizes the epigenetic mechanisms of deoxyribonucleic acid (DNA) methylation, histone modifications in cancer and the epigenetic modifications in cancer therapy. Due to their undesired side effects, the use of epigenetic drugs as chemo-drugs in cancer therapies is limited. The drug delivery system opens a door for minimizing these side effects and achieving greater therapeutic benefits. The limitations of current epigenetic therapies in clinical cancer treatment and the advantages of using drug delivery systems for epigenetic agents are also discussed. Combining drug delivery systems with epigenetic therapy is a promising approach to reaching a high therapeutic index and minimizing the side effects.

Download Full-text

Potential of Mesenchymal Stem Cells in Anti-Cancer Therapies

Current Stem Cell Research & Therapy ◽

10.2174/1574888x15666200310171547 ◽

2020 ◽

Vol 15 (6) ◽

pp. 482-491 ◽

Cited By ~ 1

Author(s):

Milena Kostadinova ◽

Milena Mourdjeva

Keyword(s):

Cancer Cells ◽

Small Population ◽

Tumor Formation ◽

Bioactive Molecules ◽

Cancer Therapies ◽

New Methods ◽

Cycle Arrest ◽

Anti Cancer ◽

Blocking Mechanisms

Mesenchymal stem/stromal cells (MSCs) are localized throughout the adult body as a small population in the stroma of the tissue concerned. In injury, tissue damage, or tumor formation, they are activated and leave their niche to migrate to the site of injury, where they release a plethora of growth factors, cytokines, and other bioactive molecules. With the accumulation of data about the interaction between MSCs and tumor cells, the dualistic role of MSCs remains unclear. However, a large number of studies have demonstrated the natural anti-tumor properties inherent in MSCs, so this is the basis for intensive research for new methods using MSCs as a tool to suppress cancer cell development. This review focuses specifically on advanced approaches in modifying MSCs to become a powerful, precision- targeted tool for killing cancer cells, but not normal healthy cells. Suppression of tumor growth by MSCs can be accomplished by inducing apoptosis or cell cycle arrest, suppressing tumor angiogenesis, or blocking mechanisms mediating metastasis. In addition, the chemosensitivity of cancer cells may be increased so that the dose of the chemotherapeutic agent used could be significantly reduced.

Download Full-text

Nitrogen Mustards as Alkylating Agents: A Review on Chemistry, Mechanism of Action and Current USFDA Status of Drugs

Anti-Cancer Agents in Medicinal Chemistry ◽

10.2174/1871520619666190305141458 ◽

2019 ◽

Vol 19 (9) ◽

pp. 1080-1102 ◽

Cited By ~ 5

Author(s):

Ghansham S. More ◽

Asha B. Thomas ◽

Sohan S. Chitlange ◽

Rabindra K. Nanda ◽

Rahul L. Gajbhiye

Keyword(s):

Side Effects ◽

Mechanism Of Action ◽

Anticancer Agents ◽

Nitrogen Mustard ◽

Alkylating Agents ◽

Cross Linking ◽

Nitrogen Mustards ◽

Information Leaflets ◽

Anti Cancer ◽

Approved Drugs

Background & Objective: :Nitrogen mustard derivatives form one of the major classes of anti-cancer agents in USFDA approved drugs list. These are polyfunctional alkylating agents which are distinguished by a unique mechanism of adduct formation with DNA involving cross-linking between guanine N-7 of one strand of DNA with the other. The generated cross-linking is irreversible and leads to cell apoptosis. Hence it is of great interest to explore this class of anticancer alkylating agents.Methods::An exhaustive list of reviews, research articles, patents, books, patient information leaflets, and orange book is presented and the contents related to nitrogen mustard anti-cancer agents have been reviewed. Attempts are made to present synthesis schemes in a simplified manner. The mechanism of action of the drugs and their side effects are also systematically elaborated.Results::This review provides a platform for understanding all aspects of such drugs right from synthesis to their mechanism of action and side effects, and lists USFDA approved ANDA players among alkylating anticancer agents in the current market.Conclusion: :Perusing this article, generic scientists will be able to access literature information in this domain easily to gain insight into the nitrogen mustard alkylating agents for further ANDA development. It will help the scientific and research community to continue their pursuit for the design of newer and novel heterocyclic alkylating agents of this class in the coming future.

Download Full-text